Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Net Cash Flow (2023 - 2025)

CG Oncology filings provide 3 years of Net Cash Flow readings, the most recent being -$12.6 million for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 105.9% to -$12.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$224.5 million, a 190.25% decrease, with the full-year FY2025 number at -$224.5 million, down 190.25% from a year prior.
  • Net Cash Flow hit -$12.6 million in Q4 2025 for CG Oncology, down from $30.5 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $213.7 million in Q4 2024 to a low of -$215.6 million in Q1 2025.
  • Median Net Cash Flow over the past 3 years was -$7.3 million (2023), compared with a mean of -$4.6 million.
  • Biggest five-year swings in Net Cash Flow: surged 10745.59% in 2024 and later tumbled 411.55% in 2025.
  • CG Oncology's Net Cash Flow stood at -$2.0 million in 2023, then surged by 10745.59% to $213.7 million in 2024, then plummeted by 105.9% to -$12.6 million in 2025.
  • The last three reported values for Net Cash Flow were -$12.6 million (Q4 2025), $30.5 million (Q3 2025), and -$26.8 million (Q2 2025) per Business Quant data.